D002491Chemicals & DrugsD27.505.954.4279150.991512Central Nervous System Agentsprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentvivo:hrJobTitleHR job titleInformation Resourcevivo:linkAnchorTextlink anchor textPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forURLLinkvivo:webpagewebpagerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson0.4622980.009878849research area of0.4280670.012845914subject area forAnesthesia and Critical Care15024966Cooper M, Metz JNeuroimaging clinics of North AmericaPositron emission tomography in central nervous system drug discovery and development. Neuroimaging Clin N Am. 2003 Nov; 13(4):851-6, xi.Neuroimaging Clin N Am2003-11-01T00:00:002003Positron emission tomography in central nervous system drug discovery and development.18657553Vezina P, Leyton MNeuropharmacologyConditioned cues and the expression of stimulant sensitization in animals and humans. Neuropharmacology. 2009; 56 Suppl 1:160-8.Neuropharmacology2008-07-09T00:00:002008Conditioned cues and the expression of stimulant sensitization in animals and humans.22288407Robson MJ, Noorbakhsh B, Seminerio MJ, Matsumoto RRCurrent pharmaceutical designSigma-1 receptors: potential targets for the treatment of substance abuse. Curr Pharm Des. 2012; 18(7):902-19.Curr Pharm Des2012-01-01T00:00:002012Sigma-1 receptors: potential targets for the treatment of substance abuse.http://tangcenter.uchicago.eduMy Group & Tang Center for Herbal Medicine ResearchNeurologyUniversity of ChicagoPaulVezinaPaul Vezina41.78927490000000-87.601250000000001492Vezina, PaulPROFESSORLarryGoldsteinLarry Goldstein41.78927490000000-87.601250000000001509Goldstein, LarryJohnMetzJohn Metz41.78927490000000-87.601250000000001658Metz, JohnRichardKraigRichard Kraig41.78927490000000-87.601250000000002091Kraig, RichardProfessorChun-SuYuanChun-Su Yuan41.78927490000000-87.60125000000000413Yuan, Chun-SuProfessortrue1true1true1ProfessorProfessortrue1ProfessorProfessortrue1PROFESSORPROFESSORPsychiatry & Behav. Neurosci12850953Goldstein LBBrain injuryNeuropharmacology of TBI-induced plasticity. Brain Inj. 2003 Aug; 17(8):685-94.Brain Inj2003-08-01T00:00:002003Neuropharmacology of TBI-induced plasticity.12937891Abou-Donia MB, Abdel-Rahman A, Goldstein LB, Dechkovskaia AM, Shah DU, Bullman SL, Khan WAArchives of toxicologySensorimotor deficits and increased brain nicotinic acetylcholine receptors following exposure to chlorpyrifos and/or nicotine in rats. Arch Toxicol. 2003 Aug; 77(8):452-8.Arch Toxicol2003-04-26T00:00:002003Sensorimotor deficits and increased brain nicotinic acetylcholine receptors following exposure to chlorpyrifos and/or nicotine in rats.